O
CDK

OppenheimerFunds’s CDK Global, Inc. CDK Stock Holding History

OppenheimerFunds’s Portfolio CDK Stock Details CDK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$575K Sell
9,771
-1,515
-13% -$82.6K ﹤0.01% 1311
2018
Q4 		$540K Buy
11,286
+756
+7% +$39.9K ﹤0.01% 1341
2018
Q3 		$659K Buy
10,530
+66
+0.6% +$4.18K ﹤0.01% 1317
2018
Q2 		$681K Buy
10,464
+597
+6% +$38.6K ﹤0.01% 1291
2018
Q1 		$625K Buy
9,867
+599
+6% +$41.9K ﹤0.01% 1298
2017
Q4 		$661K Sell
9,268
-339
-4% -$22.8K ﹤0.01% 1371
2017
Q3 		$606K Buy
9,607
+107
+1% +$6.74K ﹤0.01% 1430
2017
Q2 		$590K Buy
9,500
+1,336
+16% +$83.8K ﹤0.01% 1429
2017
Q1 		$531K Buy
8,164
+546
+7% +$35K ﹤0.01% 1478
2016
Q4 		$455K Buy
7,618
+1,757
+30% +$100K ﹤0.01% 1432
2016
Q3 		$336K Buy
5,861
+249
+4% +$14.3K ﹤0.01% 1452
2016
Q2 		$311K Sell
5,612
-828
-13% -$42.8K ﹤0.01% 1452
2016
Q1 		$300K Sell
6,440
-814
-11% -$36.2K ﹤0.01% 1454
2015
Q4 		$345K Buy
+7,254
New +$352K ﹤0.01% 1455

Other funds holding CDK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

OppenheimerFunds's CDK Position: Q1 2019 in Review

OppenheimerFunds reduced its CDK Global, Inc. (CDK) stake by 13% in Q1 2019, selling an estimated $82.6K and leaving 9,771 shares worth $575K. The position accounts for ﹤0.01% of the portfolio, ranked #1311.

OppenheimerFunds first reported a position in CDK in Q4 2015 and has held it in 14 quarters since. The position peaked at $681K in Q2 2018. 591 funds tracked by Wall St. Rank hold CDK as of Q1 2019.

  • OppenheimerFunds held 9,771 shares of CDK Global, Inc. worth $575K as of Q1 2019.
  • OppenheimerFunds sold 1,515 CDK Global, Inc. shares in Q1 2019, an estimated $82.6K.
  • CDK Global, Inc. made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1311 holding.
  • OppenheimerFunds first reported a position in CDK Global, Inc. in Q4 2015 and has held it in 14 quarters since.
  • OppenheimerFunds's CDK Global, Inc. position peaked at $681K in Q2 2018.
  • 591 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.